SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-13-052809
Filing Date
2013-07-02
Accepted
2013-07-02 08:53:45
Documents
6
Period of Report
2013-07-17
Effectiveness Date
2013-07-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A a13-15311_1def14a.htm DEF 14A 394108
2 GRAPHIC g153111cai001.gif GRAPHIC 111583
3 GRAPHIC g153111cai002.gif GRAPHIC 50307
4 GRAPHIC g153111bci001.gif GRAPHIC 2174
5 GRAPHIC g153111bci002.gif GRAPHIC 3357
6 GRAPHIC g153111bqi001.gif GRAPHIC 2174
  Complete submission text file 0001104659-13-052809.txt   629656
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 13946561
SIC: 2836 Biological Products, (No Diagnostic Substances)